StockDuty ← Dashboard Aug 26, 2026 09:15 PM ET
SignalFDA/Bio

REVOLUTION'S LIFESAVING PANCREATIC CANCER DRUG WINS SPEEDY FDA APPROVAL - REUTERS - GNEWS

FDA approval for targeted pancreatic cancer drug marks major regulatory catalyst.

What changed
Why it matters
FDA approval for targeted pancreatic cancer drug marks major regulatory catalyst.
Sources
gnews
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →